MABPHARM LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 2181 for the last semiannual is 117.55 M HKD, and it's 152.23% higher compared to the previous semiannual. The net income of H1 24 is -105.73 M HKD.